SEC Filing Summary: AspenBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio, Inc. on March 29, 2005. The registrant is incorporated in Colorado and is based in Castle Rock, CO. The filing reports on corporate updates and preliminary financial results for the fiscal year ending in 2005. Note: The request metadata referenced "Riot Platforms, Inc.," but the source document explicitly identifies the registrant as AspenBio, Inc.
Key Financial Metrics
- Revenue: Preliminary year-end revenue totaled approximately $804,000.
- Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for net income, operating cash flow, profit margins, total debt, or liquidity positions.
Material Changes
The filing announces product development progress and other corporate update matters. No specific comparative financial data for the prior period is included in this text to quantify material changes in revenue or profitability.
Guidance, Outlook, and Risks
Management highlighted product development progress in the accompanying press release (Exhibit 99.1). The filing does not contain specific forward-looking guidance, risk factors, contingencies, or details on unusual items beyond the general corporate updates.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for details on product development milestones.
- Confirm the final audited financial statements for the fiscal year to validate the preliminary $804,000 revenue figure.
- Review subsequent filings for details on cash flow, debt obligations, and liquidity status, which are absent in this 8-K.